Showing results (161-170 of 196) with videos related to
Sort By:
Pageof 20
Neuro-Oncology Advances|September 3, 2025
Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade gliomaAbiola A Ayanlaja, Michael Chang, Kriti Lalwani, et al.Cancer Discovery|May 15, 2014
Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumorsJean M Mulcahy Levy, Joshua C Thompson, Andrea M Griesinger, et al.Tobacco Control|June 7, 2006
Reductions in tobacco smoke pollution and increases in support for smoke-free public places following the implementation of comprehensive smoke-free workplace legislation in the Republic of Ireland: findings from the ITC Ireland/UK SurveyG T Fong, A Hyland, R Borland, et al.Journal of Neuro-Oncology|October 25, 2023
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumorsSydney T Grob, Kristen R Miller, Bridget Sanford, et al.Molecular Cancer Therapeutics|June 22, 2018
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood EpendymomaAndrew M Donson, Vladimir Amani, Elliot A Warner, et al.Pediatric Blood & Cancer|January 20, 2018
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapyDavis A Witt, Andrew M Donson, Vladimir Amani, et al.Marine Pollution Bulletin|December 7, 2010
Cytochrome P4501A biomarker indication of the timeline of chronic exposure of Barrow's goldeneyes to residual Exxon Valdez oilDaniel Esler, Brenda E Ballachey, Kimberly A Trust, et al.Cancer Immunology Research|May 14, 2015
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A EpendymomaAndrea M Griesinger, Rebecca J Josephson, Andrew M Donson, et al.Oncology Reports|December 6, 2017
Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine gliomaPatrick C Flannery, John A DeSisto, Vladimir Amani, et al.Journal of Neuropathology and Experimental Neurology|December 1, 2021
Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway ActivationKatherine T Lind, Hannah V Chatwin, John DeSisto, et al.Pageof 20